J S Vidal
Overview
Explore the profile of J S Vidal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schraen-Maschke S, Duhamel A, Vidal J, Ramdane N, Vaudran L, Dussart C, et al.
Neurobiol Dis
. 2024 Feb;
193:106459.
PMID: 38423192
Background And Purpose: Blood-based biomarkers are a non-invasive solution to predict the risk of conversion of mild cognitive impairment (MCI) to dementia. The utility of free plasma amyloid peptides (not...
2.
Strumia M, Vidal J, Cestac P, Sallerin B, Hanon O, Rouch L
J Am Geriatr Soc
. 2023 Sep;
71(12):3721-3730.
PMID: 37655948
Background: Blood pressure (BP) postural changes, both orthostatic hypotension (OHYPO) and orthostatic hypertension (OHYPER) are common in older adults. Few studies have investigated their association with cognition, particularly for OHYPER,...
3.
Hanon O, Vidal J, Pisica-Donose G, Benattar-Zibi L, Bertin P, Berrut G, et al.
J Nutr Health Aging
. 2015 Feb;
19(2):219-27.
PMID: 25651449
Unlabelled: Few epidemiologic studies have specifically focused on very old community dwelling population with atrial fibrillation (AF). The objectives of the AF-S.AGES cohort were to describe real-life therapeutic management of...
4.
Duron E, Boulay M, Vidal J, El Bchiri J, Fraisse M, Rigaud A, et al.
J Nutr Health Aging
. 2013 Mar;
17(4):385-9.
PMID: 23538663
Context: Some studies have highlighted the difficulty for physicians to evaluate patient's ability to consent to bio-medical research in the elderly population. The University of California Brief Assessment of Capacity...
5.
Verneuil L, Marchand C, Vidal J, Ze Bekolo R, Daurel C, Lebouvier G, et al.
Br J Dermatol
. 2010 Apr;
163(2):329-33.
PMID: 20426786
Background: Pristinamycin is used for the treatment of Staphylococcus aureus skin infection. Staphylococcus aureus pristinamycin resistance is usually low. The frequency of pristinamycin-resistant S. aureus (PRSA) increased in the Caen...
6.
Djebbari R, du Montcel S, Sangla S, Vidal J, Gallouedec G, Vidailhet M
J Neurol Neurosurg Psychiatry
. 2004 Nov;
75(12):1688-91.
PMID: 15548483
Objective: To identify factors predicting improvement in motor disability in writer's cramp treated with botulinum toxin (BTX). Methods: 47 patients with writer's cramp were treated with BTX and were evaluated...
7.
Levecque C, Elbaz A, Clavel J, Vidal J, Amouyel P, Alperovitch A, et al.
J Neurol Neurosurg Psychiatry
. 2004 Feb;
75(3):478-80.
PMID: 14966169
Background: The Saitohin gene has recently been identified in intron 9 of the Tau gene. Because an association between Parkinson's disease and Tau has been described, Saitohin represents a candidate...
8.
Vidal J, Derkinderen P, Vidailhet M, Thobois S, Broussolle E
J Neurol Neurosurg Psychiatry
. 2003 Aug;
74(9):1352-3.
PMID: 12933961
No abstract available.
9.
Sangla S, Trocello J, Bourdain F, Vidal J, Gallouedec G, Vidailhet M
Ann Readapt Med Phys
. 2003 Aug;
46(6):307-11.
PMID: 12928135
Botulinum toxin has been a useful treatment in many movement disorders and more recently in other non-neurological motor dysfunctions for more than 15 years. Here, we review the various indications...
10.
Vidailhet M, Derkinderen P, Vidal J, Sangla S
Joint Bone Spine
. 2001 Jun;
68(4):325-8.
PMID: 11402463
No abstract available.